State Street Corp's Strategic Reduction in Editas Medicine Inc Holdings

Published on 17 Oct 2024 on GuruFocus.com · via Yahoo Finance

State Street Corp's Strategic Reduction in Editas Medicine Inc Holdings

Overview of Recent Transaction by State Street Corp

On September 30, 2024, State Street Corp executed a significant transaction involving the sale of 2,128,891 shares of Editas Medicine Inc (NASDAQ:EDIT), a pioneering firm in the biotechnology sector. This move reduced their holding to 2,462,022 shares, reflecting a notable shift in their investment strategy regarding EDIT. The shares were traded at a price of $3.41, marking a pivotal adjustment in State Street Corp's portfolio.

Profile of State Street Corp

Read the rest of the article

NASDAQ.EDIT price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

EDIT Stock Falls on Decision to End Reni-Cel Studies, Cut Workforce

Editas stock falls as it ends development of reni-cel for SCD and TDT following failed attempts t...

Zacks · via Yahoo Finance 16 Dec 2024

Gene-editing pioneer Editas lays off more than half its employees - Boston...

Big changes, including major layoffs, are coming at Editas Medicine Inc. as the biotech lays off ...

The Business Journals 13 Dec 2024

Editas Medicine Realigns Strategy to Focus on In Vivo Gene Editing, Targets...

On Thursday, Editas Medicine Inc. (NASDAQ:EDIT) announced a strategic realignment to focus on in...

Benzinga · via Yahoo Finance 13 Dec 2024

Is Editas Medicine, Inc. (EDIT) a Promising Gene Editing Stock?

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge...

Insider Monkey · via Yahoo Finance 31 Oct 2024

State Street Corp's Strategic Reduction in Editas Medicine Inc Holdings

Overview of Recent Transaction by State Street Corp On September 30, 2024, State Street Corp exec...

GuruFocus.com · via Yahoo Finance 17 Oct 2024

What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with...

We recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...

Insider Monkey · via Yahoo Finance 19 Jun 2024

Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 19 Jun 2024

EVP, Chief Financial Officer Erick Lucera Sells 22,337 Shares of Editas Medicine Inc

Erick Lucera, the EVP, Chief Financial Officer of Editas Medicine Inc (NASDAQ:EDIT), sold 22,337 ...

GuruFocus.com via Yahoo Finance 23 May 2024

Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc

On May 13, 2024, Jessica Hopfield, Director at Editas Medicine Inc (NASDAQ:EDIT), purchased 45,00...

GuruFocus.com via Yahoo Finance 16 May 2024

Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest...

Editas Medicine, Inc. (NASDAQ:EDIT) just released its latest quarterly report and things are not ...

Simply Wall St. via Yahoo Finance 9 May 2024

News

State Street Corp's Strategic Reduction in Editas Medicine Inc Holdings

NASDAQ.EDIT price evolution

Want to become a better investor?